Marlborough, Massachusetts--(Newsfile Corp. - December 10, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO),) is a clinical-stage biotechnology company developing therapeutics...
– Vepdegestrant in combination with abemaciclib demonstrated encouraging clinical activity (clinical benefit rate: 62.5%; overall response rate: 26.7%) in patients...
GREENWICH, Conn., Dec. 10, 2024 (GLOBE NEWSWIRE) -- Oxford Lane Capital Corp. (Nasdaq: OXLC) (NasdaqGS: OXLCP) (NasdaqGS: OXLCL) (NasdaqGS: OXLCO)...
HERZLIYA, Israel, Dec. 10, 2024 (GLOBE NEWSWIRE) -- Nayax Ltd. (Nasdaq: NYAX; TASE: NYAX), a global commerce enablement payments and...
HIGHLIGHTS Novo strengthens its high-quality, Australian based exploration portfolio by securing a significant new ground position of approximately 1,520 sq...
Tuesday, December 10, 2024 Dear Shareholders and Investors, Non-Executive Vice Chairman of NAT, Alexander Hansson, has today bought...
HOUSTON, Dec. 10, 2024 (GLOBE NEWSWIRE) -- Marker Therapeutics, Inc. (Nasdaq: MRKR), a clinical-stage immuno-oncology company focusing on developing next-generation...
SINGAPORE, Dec. 10, 2024 (GLOBE NEWSWIRE) -- MoneyHero Limited (Nasdaq: MNY) (“MoneyHero” or the “Company”), a market leading personal finance...
Sheridan, Wyoming--(Newsfile Corp. - December 10, 2024) - LSEB Creative Corp. (OTCQB: LSEB) (the "Company"), a visionary new entrant in...
WINTER SPRINGS, Fla., Dec. 10, 2024 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD), today announced it has been...
Boca Raton, Florida, Dec. 10, 2024 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage inflammation and...
ATHENS, Greece, Dec. 10, 2024 (GLOBE NEWSWIRE) -- Imperial Petroleum Inc. (Nasdaq: IMPP) (the “Company”), a ship-owning company providing petroleum...
Third Quarter GAAP and Non-GAAP Net Income Per Diluted Share Exceed GuidanceNet Sales of $1.09 Billion for the Third Quarter...
BETHESDA, MD, Dec. 10, 2024 (GLOBE NEWSWIRE) -- HWH International Inc. (“HWH”) (Nasdaq: HWH) is proud to announce the signing...
MOU provides the basic framework, required to design, build, and operate a manufacturing facility for advanced silicon-based anode materials for...
Third Quarter GAAP and Non-GAAP Net Income Per Diluted Share Exceed GuidanceNet Sales of $1.09 Billion for the Third Quarter...
BASKING RIDGE, N.J., Dec. 10, 2024 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata”), a clinical-stage pharmaceutical company developing...
Fort Lauderdale, Florida--(Newsfile Corp. - December 10, 2024) - Flora Growth Corp. (NASDAQ: FLGC) (FSE: 7301) ("Flora" or the "Company")...
BASKING RIDGE, N.J., Dec. 10, 2024 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata”), a clinical-stage pharmaceutical company developing...
DeFi Technologies Signs LOI for 10% Stake in Neuronomics AG: DeFi Technologies will acquire a minority stake in Neuronomics AG,...
NORTH CANTON, Ohio, Dec. 10, 2024 /PRNewswire/ -- Diebold Nixdorf, Incorporated (NYSE: DBD) (the "Company") today announced that it has...
New Brunswick, NJ, Dec. 10, 2024 (GLOBE NEWSWIRE) -- DatChat, Inc (Nasdaq: DATS), a secure messaging and social media company,...
Nearly $2.4 million awarded to 171 nonprofits in Virginia Grants awarded to 318 nonprofits across six states Funding supports human...
PASADENA, Texas--(BUSINESS WIRE)--Chevron U.S.A., Inc. (CUSA), a wholly owned subsidiary of Chevron Corporation (NYSE: CVX), has completed a retrofit of...
BOSTON, Dec. 10, 2024 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based...
Companies Collaborating on Global Sales and Marketing TULSA, Okla., Dec. 10, 2024 /PRNewswire/ -- ClearSign Technologies Corporation (Nasdaq: CLIR) ("ClearSign"),...
ANDOVER, Mass., Dec. 10, 2024 (GLOBE NEWSWIRE) -- Byrna Technologies Inc. (“Byrna” or the “Company”) (Nasdaq: BYRN), a technology company,...
Viasat will support U.S. Department of Defense (DoD) technology modernization with tactical networking, ground system, satellite communication and cybersecurity solutions...
KEARNEY, Neb.--(BUSINESS WIRE)--The Buckle, Inc. (NYSE: BKE) announced that at its quarterly meeting of the Board of Directors, held on...
Vancouver, British Columbia--(Newsfile Corp. - December 10, 2024) - Bayhorse Silver Inc, (TSXV: BHS) (OTCQB: BHSIF) (FSE: 7KXN) (the "Company"...
LOS ANGELES, Dec. 10, 2024 (GLOBE NEWSWIRE) -- ViaDerma, Inc. (OTC Pink: VDRM), an innovator in transdermal drug delivery and...
MEMPHIS, Tenn., Dec. 10, 2024 (GLOBE NEWSWIRE) -- AutoZone, Inc. (NYSE: AZO) today reported net sales of $4.3 billion for...
ATLANTA, Dec. 10, 2024 (GLOBE NEWSWIRE) -- Today, Acuity Brands, Inc. (NYSE: AYI) ("Acuity," “Company”), a market-leading industrial technology company, released...
– Phase 2 TRANQUILITY trial surpasses enrollment target, with 143 total patients enrolled; topline data expected in second quarter of...
– Vepdegestrant in combination with abemaciclib demonstrated encouraging clinical activity (clinical benefit rate: 62.5%; overall response rate: 26.7%) in patients...
Interim safety and pharmacokinetic data from Phase 1 healthy volunteers trial anticipated in 2H 2025 APG777 + APG333 can potentially...
SUNNYVALE, Calif.--(BUSINESS WIRE)--Alpha and Omega Semiconductor Limited (AOS) (Nasdaq: AOSL), a designer, developer, and global supplier of a broad range...
MARLBOROUGH, Mass. and FRANKFURT, Germany, Dec. 10, 2024 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA), The Spatial Biology Company,...
BARTLETT, Tenn., Dec. 10, 2024 /PRNewswire/ -- SurgePays, Inc. (Nasdaq: SURG) has fully integrated its ClearLine software marketing platform with Clover's...
- 32% objective response rate (ORR) in evaluable patients at the 5.2 mg/kg starting dose – the selected dose for...
